Browse All
Displaying 1 - 5 of 10
Author:Wong, Ka-Ho Marini, Erica Francis, Trieste Kadish, Robert Galli, Jonathan Paz Soldan, M. Klein, Julia Sorenson, Abigail King, Jordan Rose, John Smith, Tammy Clardy, Stacey
Session Name:S31: Multiple Sclerosis: Therapeutics and Clinical Decision Making
Topic:Multiple Sclerosis
Program Number:S31.001
Author Institution:U of U Neurology Clinic, Salt Lake City, UT University of Utah, Salt Lake City, UT University of Utah School of Medicine, Salt Lake City, UT UC Berkeley, Berkeley, CA Imaging and Neurosciences Center, Salt Lake City, UT
Author:Singhal, Tarun Zurawski, Jonathan Cicero, Steven Vaquerano, Steven Dubey, Shipra Saraceno, Taylor Howard, Danielle Sullivan, John Clementi, Nancy Weiner, Howard Chitnis, Tanuja
Program Number:S31.002
Author Institution:Brigham and Women's Hospital, Boston, MA Clementi & Associates Ltd., Rosemont, PA
Author:Pardo, Gabriel Hauser, Stephen Bar-Or, Amit Gold, Ralf Montalban, Xavier Cohen, Jeffrey Robertson, Derrick Hersh, Carrie Naismith, Robert Deiva, Kumaran Bhatt, Alit Fu, Haoyi Boer, Ibolya Meuth, Sven Cross, Anne Gärtner, Jutta Kappos, Ludwig
Program Number:S31.003
Author Institution:Oklahoma Medical Research Foundation, Oklahoma, USA, Oklahoma City, OK UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA, San Francisco, CA Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA Department of Neurology, Katholisches Klinikum Bochum, Ruhr-Universität Bochum, Bochum, Germany, Bochum, Germany Department of Neurology Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron, Barcelona, Spain, Barcelona, Spain Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA, Cleveland, OH Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, Florida, USA, Tampa, FL Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, United States, Las Vegas, NV Department of Neurology, Washington University School of Medicine, Saint Louis, Missouri, USA, Saint Louis, MO Department of Pediatric Neurology, University Hospitals Paris Saclay, Hôpital Bicêtre, National Reference Center for Rare Inflammatory Brain and Spinal Diseases, Le Kremlin Bicêtre, France, Le Kremlin Bicêtre, France Novartis Healthcare Pvt. Ltd., Hyderabad, India, Hyderabad, India Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, East Hanover, NJ Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland Department of Neurology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany, Duesseldorf, Germany Department of Neurology, Section of Neuroimmunology, Washington University School of Medicine, Saint Louis, Missouri, USA, Clayton, MO Department of Paediatrics and Adolescent Medicine, Division of Paediatric Neurology, University Medical Centre Göttingen, Georg August University Göttingen, Göttingen, Germany, Göttingen, Germany Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Head, Organs, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland
Author:Bar-Or, Amit Dufek, Michal Budincevic, Hrvoje Drulovic, Jelena Habek, Mario Hua, Le H Weber, Martin S. Thomas, Piia Napieralski, Julie Clayton, David Kuruvilla, Denison Qi, Qi Xu, Yan Goodyear, Alexandra Oh, Jiwon
Program Number:S31.004
Author Institution:University of Pennsylvania, Philadelphia, PA St. Anne’s University, Brno, Czech Republic Sveti Duh University Hospital, Zagreb, Croatia University Clinical Center of Serbia, Belgrade, Serbia University Hospital Center Zagreb and University of Zagreb, School of Medicine, Zagreb, Croatia Lou Ruvo Center for Brain Health, Las Vegas, NV Institute of Neuropathology and Department of Neurology, University Medical Center, Göttingen, Germany Genentech Inc., South San Francisco, CA St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada
Author:Hauser, Stephen Kappos, Ludwig Filippi, Massimo Wolinsky, Jerry Weber, Martin Nicholas, Jacqueline Chognot, Cathy Schneble, Hans-Martin Wang, Qing Giovannoni, Gavin Montalban, Xavier
Program Number:S31.005
Author Institution:UCSF Weill Institute for Neurosciences, San Francisco, CA University Hospital Basel, University of Basel, Research Center for Clinical Neuroimmunology and Neuroscience, Basel, Switzerland Ospedale San Raffaele, Neuroimaging Research Unit, Milan, Italy McGovern Medical School, UTHealth, Houston, TX Institute of Neuropathology and Department of Neurology, Göttingen, Germany OhioHealth Riverside Methodist Hospital, Columbus, OH F. Hoffmann-La Roche Ltd., Basel, Switzerland Queen Mary University, London, United Kingdom Vall d’Hebron University Hospital, Barcelona, Spain
